Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/11/16  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Rhett M. Schiffman MD MS MHSA

Wrong Dr. Rhett M. Schiffman MD MS MHSA?

Vice President, Development

Phone: (714) ***-****  
Local Address:  IRVINE , California , United States
Allergan , Inc.
2525 Dupont Drive
Irvine , California 92612
United States

Company Description: Allergan, Inc. is a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices. The Company is...   more
Background

Employment History

Education

  • B.S. , Bioengineering
    Columbia University
  • BS , Bioengineering
    Columbia University , School of Engineering and Applied Sciences
  • M.D.
    University of Juarez , Mexico
  • MS
  • Master's degrees , Clinical Research Design and Statistical Analysis and in Health Services Administration
    University of Michigan
82 Total References
Web References
MANAGEMENT | Envisia
www.envisiatherapeutics.com [cached]
Rhett M. Schiffman, M.D.
Chief Medical Officer & Executive Vice President, Research & Development
Dr. Rhett Schiffman is Senior Vice President of Development and Chief Medical Officer at Envisia. Previously, Dr. Schiffman was the Chief Medical Officer at Neurotech Pharmaceuticals where he led the company's NT-503 program through phase 1/2 clinical trials. Prior to Neurotech, he was Vice President of Global Drug Development and Therapeutic Area Head of Ophthalmology at Allergan where he played a key role in the global development and approval of many successful products including Restasis®, Combigan®, Lumigan®, Acuvail®/Acular®. Zymaxid®/Zymar®, as well as Lumigan® and Ganfort® unit dose products. Dr. Schiffman received his B.S. in Bioengineering from Columbia University and his M.D. from the University of Juarez, Mexico. He also received Master's degrees from the University of Michigan in Clinical Research Design and Statistical Analysis and in Health Services Administration. He completed residencies in both Internal Medicine and Ophthalmology at Henry Ford Hospital in Michigan and is Board Certified in both specialties and completed a Uveitis fellowship at the National Eye Institute at the National Institutes of Health. He has served on the Board of Directors of the Glaucoma Research Foundation and is Associate Clinical Professor of Ophthalmology at the University of California at Irvine where he sees patients and teaches residents.
Executive Team & Board Of Directors | Neurotech Pharmaceuticals
www.neurotechusa.com [cached]
Chief Medical Officer Rhett Schiffman
...
Rhett Schiffman, M.D., M.S., M.H.SA
Chief Medical Officer
Dr. Schiffman joined Neurotech as CMO in September 2013. Rhett Schiffman was most recently Vice President of Global Drug Development and Therapeutic Area Head of Ophthalmology at Allergan, where since 2001 he was instrumental in the global development and approval of many of ophthalmology's most successful products including Restasis®, Combigan®, Lumigan®, Acuvail® and Acular®, Zymaxid® and Zymar® and most recently, the Lumigan® and Ganfort® unit dose products. He also currently serves on the Board of Directors of the Glaucoma Research Foundation and is Associate Clinical Professor of Ophthalmology at the University of California at Irvine. Dr. Schiffman received his B.S. in Bioengineering from Columbia University, School of Engineering and Applied Sciences and his M.D. from the University of Juarez, Mexico. He also received Master's degrees from the University of Michigan in Clinical Research Design and Statistical Analysis and in Health Services Administration. He completed residencies in both Internal Medicine and Ophthalmology at Henry Ford Hospital, is Board Certified in both and completed a Uveitis fellowship at the National Eye Institute at the National Institutes of Health.
Board of Directors | Glaucoma Research Foundation
www.glaucoma.org [cached]
Rhett M. Schiffman, MD, MS, MHSA
Chief Medical Officer Neurotech Pharmaceuticals
Press Releases - All Articles
www.glaucoma.org [cached]
Allergan VP Dr. Rhett Schiffman Joins Board of Directors
Rhett M. Schiffman, MD, MS, MHSA, the Vice President of Global Drug Development and Therapeutic Area Head of Ophthalmology at Allergan, Inc., has joined the Board of Directors.
Board of Directors | Glaucoma Research Foundation
www.glaucoma.com [cached]
Rhett M. Schiffman, MD, MS, MHSA
Vice President of Global Drug Development and Therapeutic Area Head of Ophthalmology Allergan, Inc.
Other People with the name "Schiffman":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304